FDA Inspection 1083165 — Mass General Brigham Inc. IRB
The FDA completed an inspection of Mass General Brigham Inc. IRB on February 14, 2019 in Somerville, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 14, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Somerville, MA (United States)
Additional Details
IRB